ACE inhibition and fibroblast growth factor in cultured human vascular smooth muscle

Abstract

The effects of the angiotensin converting enzyme (ACE) inhibitor, enalaprilat, and basic fibroblast growth factor (bFGF) on DNA synthesis and expression of ACE mRNA were examined in human vascular smooth muscle cells cultured from saphenous vein and internal mammary artery.

DNA synthesis was estimated using 3H-thymidine uptake, and ACE mRNA was estimated by rt-PCR. Enalaprilat (0.125 mg/ml, 48 h) decreased 3H-thymidine uptake to 66 - 12% (SE) of the control without enalaprilat (p, 0.05). Basic FGF (10 ng/ml, 24 h) increased uptake by 41 - 12% (p, 0.05) while enalaprilat pretreatment (24 h) decreased uptake to 56 - 12% of this augmented value (p, 0.025). Basic FGF increased ACE mRNA, a process that was time dependent with an approximately 50% increase after 24 h exposure. Pre-exposure to enalaprilat (24 h) before bFGF reduced ACE mRNA to approximately 50% of that found in the presence of bFGF alone.

The results indicate that ACE mRNA is present in human vascular smooth muscle cells and that exposure to an ACE inhibitor reduces DNA synthesis. Basic FGF stimulates DNA synthesis and ACE mRNA expression, and both of these effects are reduced by an ACE inhibitor. The results are consistent with the effects of bFGF being exerted through, or alternatively in concert with, angiotensin II. Further, they suggest that ACE inhibition can reduce the activity of the renin-angiotensin system by inhibiting the production of ACE, or at least the expression of ACE mRNA, in addition to producing enzyme inhibition at the ACE level.

Keywords

angiotensin converting enzyme inhibition enalaprilat fibroblast growth factor human smooth muscle vascular smooth muscle

References

Dzau VJ. Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation 1988; 77: I4-I13.

Griendling KK , Murphy TJ , Alexander RW. Molecular biology of the renin-angiotensin system. Circulation 1993; 87: 1816-1828.

Gibbons GH , Pratt RE , Dzau VJ. Vascular smooth muscle cell hypertrophy vs hyperplasia. Autocrine transforming growth factor-b1 expression determines growth response to angiotensin II. J Clin Invest 1992; 90: 456-461.

Itoh H , Mukoyama M , Pratt RE , Gibbons GH , Dzau VJ. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest 1993; 91: 2268-2274.

Bagby SP , Kirk EA , Mitchell LH et al. Proliferative synergy of angiotensin II and EGF in porcine aortic vascular smooth muscle cells. Am J Physiol 1993; 265: F239-F49.

Kanzaki M , Nobusawa R , Mogami H , Yasuda H , Kawamura N , Kojima I. Production of activin A and follistatin in cultured rat vascular smooth muscle cells. Mol Cell Endocrinol 1995; 108: 11-16.

Hahn AWA , Schmidt R , Kern F , Resink TJ , Bühler FR. Endothelium-modulated proliferation of medial smooth muscle cells: influence of angiotensin II and converting enzyme inhibition. Eur Heart J 1995; 16: C29-C32.

Daemen MJAP , Lombardi DM , Bosman FT , Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 1991; 68: 450-456.

Rakugi H , Duk-Kyung K , Krieger JE , Wang DS , Dzau VJ , Pratt RE. Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis. J Clin Invest 1994; 93: 339-346.

10.

Larrue J , Demond-Henri J , Daret D. Renin-angiotensin system in cultured human arterial smooth muscle cells. J Cardiovasc Pharmacol 1989; 14: 543-545.

11.

Battle T , Arnal JF , Challah M , Michel JB. Selective isolation of rat aortic wall layers and their vell types in culture-application to converting enzyme activity measurement. Tissue Cell 1994; 26: 943-955.

12.

Arnal JF , Battle T , Rasetti C et al. ACE in three tunicae of rat aorta: expression in smooth muscle and effect of renovascular hypertension. Am J Physiol 1994; 267: H1777-H84.

13.

Fishel RS , Thourani V , Eisenberg SJ et al. Fibroblast growth factor stimulates angiotensin converting enzyme expression in vascular smooth muscle cells. Possible mediator of the response to vascular injury. J Clin Invest 1995; 95: 377-387.

14.

Fishel RS , Eisenberg S , Shai SY , Redden RA , Bernstein KE , Berk BC. Glucocorticoids induce angiotensin-converting enzyme expression in vascular smooth muscle. Hypertension 1995; 25: 343-349.

15.

Lanzillo JJ , Kong XJ , Fanburg BLA. Competitive deletion mutant quantitative PCR assay for angiotensin-converting enzyme mRNA in smooth muscle cells. PCR Methods Appl 1994; 4: 167-171.

16.

Powell JS , Rouge M , Muller RK , Baumgartner HR. Cilazapril suppresses myointimal proliferation after vascular injury: effects on growth factor induction in vascular smooth muscle cells. Basic Res Cardiol 1991; 86: S65-S74.

17.

Lehmann K , Powell JS. Effect of cilazapril on the proliferative response after vascular damage. J Cardiovasc Pharmacol 1993; 22: S19-S24.

18.

Zhu Z , Tepel M , Neusser M , Zidek W. Transforming growth factor beta 1 modulates angiotensin II-induced calcium influx in vascular smooth muscle. Eur J Clin Invest 1995; 25: 317-321.

19.

Berk BC , Rao GN. Angiotensin II-induced vascular smooth muscle cell hypertrophy: PDGF A-chain mediates the increase in cell size. J Cell Physiol 1993; 154: 368-380.

20.

Temizer DH , Yshizumi M , Perrella MA , Susanni EE , Quertermous T , Lee ME. Induction of heparin-binding epidermal growth factor-like growth factor mRNA by phorbol ester and angiotensin II in rat aortic smooth muscle cells. J Biol Chem 1992; 267: 24892-24896.

21.

Endo-Mochizuki Y , Mochizuki N , Sawa H et al. Expression of renin and angiotensin-converting enzyme in human hearts. Heart Vessels 1995; 10: 285-293.

22.

Baier G , Telford D , Gulbins E , Yamada N , Kawakami T , Altman A. Improved specificity of RT-PCR amplifications using nested cDNA primers. Nucleic Acid Res 1993; 21: 1329-1330.

23.

Okabe T , Yamagata K , Fujisawa M , Takaku F , Hidaka H , Umezawa Y. Induction by fibroblast growth factor of angiotensin converting enzyme in vascular endothelial cells in vitro. Biochem Biophys Res Commun 1987; 145: 1211-1216.

24.

Uehara Y , Numabe A , Kawabata Y et al. Inhibition of protein synthesis and antiproliferative effect of the angiotensin converting enzyme inhibitor trandolaprilat in rat vascular smooth muscle cells. J Hypertens 1993; 11: 1073-1081.

25.

Sachinidis A , Ko Y , Graack GK , Wieczorek AJ , Vetter H. Action of metoprolol, enalapril, diltiazem, verapamil and nifedipine on cell growth of vascular smooth muscle cells. J Cardiovasc Pharmacol 1992; 19: S60-S62.